Bromide

Bromide

SCHEMBL4189519

Br.NN1CCNCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104481 0.96
Fluoride SCHEMBL27859430 0.93
SCHEMBL14157886 0.93 HIF1A (0.33)
Methane SCHEMBL28187408 0.93
SCHEMBL15855949 0.93 HIF1A (0.43)
SCHEMBL2035218 0.93 HIF1A (0.43)
Hydrochloric Acid SCHEMBL19547768 0.93
SCHEMBL31047466 0.93
Hydrazine SCHEMBL8005298 0.93
Iodide SCHEMBL27846717 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175818-B2 Extraction of metals with diquaternary ammonium salts LYNNTECH, INC. (US) 2007-02-13 US claimed
WO-2005071121-A1 EXTRACTION OF METALS WITH DIQUATERNARY AMMONIUM SALTS LYNNTECH, INC. (US) 2005-08-04 WO claimed
US-6890496-B2 Extraction of metals with diquaternary amines LYNNTECH, INC. (US) 2005-05-10 US claimed
US-20040200782-A1 Extraction of metals with diquaternary ammonium salts CITY BANK 2004-10-14 US claimed
CN-106999572-A Therapeutic compositions and methods for inducing an immune response to herpes simplex virus type 2 (HSV-2) 阿德梅杜斯疫苗有限公司 2017-08-01 CN disclosed
CN-104159900-B Substituted benzothienyl-pyrrolo-triazine and the purposes in treatment of cancer thereof 拜耳知识产权有限责任公司 2016-08-24 CN disclosed
CN-100463720-C Phase-transferring catalyst containing dinaphthalene chiral double-spiral quaternary ammonium and its production UNIV TIANJIN (CN) 2009-02-25 CN disclosed
WO-2009005917-A2 METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS VICAL INCORPORATED (US) 2009-01-08 WO disclosed
CN-101073780-A Phase-transferring catalyst containing dinaphthalene chiral double-spiral quaternary ammonium and its production UNIV TIANJIN (CN) 2007-11-21 CN disclosed